Wealth

Floods in Europe, forest fires in North America and Australia—the impact and tragic results of climate change are starting to dominate the news.

The actions taken by governments, companies and individuals in the next decade will be crucial if we are to limit the rise in global temperatures. The option of doing nothing has now passed, not just for the environment, but for companies and investors too.

Grosvenor Group seeks ESG commercial property deals beyond London

Grosvenor Group, the London-headquartered international property businesses owned by the Duke of Westminster and family, looks to expand in the regions of the United Kingdom with its ESG–minded $415 million investment strategy.

The new strategy followed losses in asset values and revenue as Covid-19 pandemic restrictions impacted high street retail in 2020.

Molly Heaney, a fifth-generation director of JM Huber, one of the largest privately-owned businesses in the United States, says her family’s set of guiding principles remain the corporation’s “North Star” in its accelerating pace of investments.

Huber is a portfolio management company and a global leader in hydrocolloids, specialty chemicals and minerals and engineered woods, supplying industries such as agrochemicals, beverages, household products, oral care, paper, energy, plastics and construction.

The medical technology industry is enjoying record levels of M&A activity. Deloitte’s 2020 MedTech review identified a 24% increase in transactions in Western Europe, with strong focus on diagnostics, orthopaedics and data driven innovation.

For many investors the strong growth prospects, resilient valuations and defensive nature of healthcare investments make this a very attractive market. Evaluate MedTech calculates $6 billion of venture financing was invested in 2019 and 2020, slightly down from the 2017 high of $7.8 billion.